Gilead-Medivir Hepatitis C Drug Clears Virus in Patients

An experimental drug combination from Gilead Sciences Inc., Medivir AB and Johnson & Johnson eradicated the virus that causes hepatitis C in patients with the liver disease in a study.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.